How to Reconstitute 5mg Tirzepatide — and Why This Question Is a Red Flag

The decision in front of you: proceed with what you have, or stop?

This is the real question, and it is worth sitting with for a moment before you reach for a syringe. The licensed Mounjaro 5mg KwikPen (the form Eli Lilly manufactures for the UK market) contains a clear, ready-to-inject solution. Twist off the cap, attach the needle, dial, inject. There is no powder to dissolve, no bacteriostatic water to measure, no concentration to calculate. The Mounjaro 5mg pen requires nothing from you except correct injection technique and storage in the fridge at 2–8°C.

So if instructions have arrived telling you to reconstitute 5mg tirzepatide at home, the product in your hands is not the licensed medicine. It may be a raw peptide sold through research-chemical channels, an unlicensed compound, or something worse. The MHRA has documented counterfeit weight-loss pens containing insulin and other substances, a fake pen looks convincing and the consequences of injecting the wrong compound can be serious. Before you proceed with anything, that is the decision to make: not how to mix it, but whether to use it at all.

You can learn more about what genuine tirzepatide looks like in the UK on the Mounjaro overview page.

What reconstitution actually involves, and why it is not a home process

Reconstitution in a clinical context means adding a measured volume of sterile diluent (usually bacteriostatic water for injection) to a vial of lyophilised peptide powder, then drawing the resulting solution into a syringe at a calculated concentration. The process requires accurate sterile technique, a correctly calculated volume-to-dose ratio, pH-appropriate diluent, and cold-chain storage of the finished solution, typically at 2–8°C for no more than a few weeks.

Even in a well-equipped setting, errors in reconstitution change the effective dose substantially. At home, without pharmaceutical-grade equipment, the risks multiply: contamination, incorrect concentration, particulate matter, and injecting a substance whose actual content has never been independently verified. The NHS tirzepatide medicines page confirms that the licensed product is supplied ready to use; nothing in the patient information leaflet describes a reconstitution step because none exists for Mounjaro. Anyone directing you toward tirzepatide 5mg reconstitution as a normal part of home treatment is describing a different (and unlicensed) product.

For those curious about what higher doses look like in the same licensed format, the process is identical at every strength: pre-filled pen, no mixing required. The 10mg page and the 15mg page address the same question for those doses and reach the same conclusion.

Why people encounter powder-form tirzepatide, and the supply-chain reality

Raw tirzepatide peptide is synthesised and sold legally for laboratory research. It reaches consumers through grey-market peptide suppliers, often marketed with careful wording that stops just short of explicit medical claims. Some sellers supply bacteriostatic water and insulin syringes alongside the vials, framing reconstitution as a normal step. The appeal is usually price: a vial sold this way can appear far cheaper than a licensed pen.

The cost comparison does not hold up once you account for what is absent. No clinical assessment. No prescriber oversight. No verified manufacturing standards. No patient information leaflet. No regulated supply chain. The MHRA has been clear in its public guidance on GLP-1 medicines that these products are not assessed for quality or safety, and that purchasing them exposes users to unknown risks. In 2025, around 20 million doses of illegally traded weight-loss medicines (worth approximately £45 million) were seized. One raid uncovered a UK site manufacturing counterfeit tirzepatide pens in Northampton.

Cost is not an irrelevant factor in a genuine treatment decision; the cost context page for Mounjaro covers private pricing honestly. But for a prescription medicine, the right question is not which listing is cheapest, it is whether the product is genuinely what it claims to be. That verification only happens through the licensed supply chain.

What a legitimate route to 5mg tirzepatide looks like in practice

Through a GPhC-registered online pharmacy, the process is straightforward. You complete a clinical consultation (free at nume) and a named GPhC-registered Independent Prescriber reviews your answers the same day. Not software. A real clinician, reading your case. Identity and weight are verified before any prescription is issued. If clinically suitable, the pen is dispensed from the licensed UK supply chain and dispatched the same working day for free next-working-day tracked delivery via DPD, in plain packaging.

Treatment typically begins at 2.5mg (a starting dose designed to let your system adjust) and moves to 5mg at the prescriber's direction, usually after four weeks. The treatment page sets out the full process and current options. The weight-loss overview puts tirzepatide in context alongside other licensed medicines. Worth noting: orders placed by midday Monday to Friday, once approved, go out that day, useful to know if you are planning around a bank holiday or a busy week.

If you are already on treatment sourced elsewhere and want to transfer, our prescribers will ask for evidence of your current dose and recent weight. That step exists to protect you, not to create paperwork. You can read about our clinical team on the clinical lead's profile page, or browse common questions on the FAQs page. If something about your current product or instructions concerns you, the contact page reaches our support team directly.

Check your eligibility through a free consultation, that is where the clinical picture gets assessed properly, and the right answer for your situation becomes clear.